Filing Flows › Industrials › Antiaging Quantum Living (AAQL)
Antiaging Quantum Living (AAQL) earnings and revenue breakdown
Latest: Q1 FY27 · 10-Q filed Aug 14, 2026 · Antiaging Quantum Living (AAQL) Q1 FY27 earnings results →
Q1 FY27 Revenue up 150% year over year to $730K · 44¢ of every $1 of revenue lost · operating margin -44.2%
Antiaging Quantum Living made $730K in Q1 FY27 (+150% Y/Y). Operating margin -44.2%, net loss $319K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $730K in Q1 FY27, up 151% year over year and up 5745% from the previous quarter.
Gross margin was 42.9%, down 37.7 points from Q1 FY26. Operating costs exceeded revenue by $323K, an operating margin of -44.2%. Operating expenses grew 71% against revenue growth of 151%. The fastest-growing cost line was Sales & marketing (+2560%). The quarter ended with a net loss of $319K, narrower than the previous quarter's $371K loss.
Operating cash flow was −$472K. Non-cash charges added back $10K of depreciation and amortization. Working capital and other items used $163K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q1 FY27 | 10-Q | Aug 14, 2026 | $730K | +150% | -44.2% | −$319K | −$472K |
| Q4 FY26 | 10-K | Jul 14, 2026 | $12K | -96% | n/m | −$371K | −$426K |
| Q3 FY26 | 10-Q | Feb 13, 2026 | $340K | +120% | -80.0% | −$272K | $346K |
| Q2 FY26 | 10-Q | Nov 12, 2025 | $390K | +125% | -13.1% | −$62K | $93K |
| Q1 FY26 | 10-Q | Aug 14, 2025 | $291K | +44% | -47.4% | −$133K | −$185K |
| Q4 FY25 | 10-K | Jul 2, 2025 | $288K | — | -62.3% | −$180K | −$333K |
| Q3 FY25 | 10-Q | Feb 19, 2025 | $154K | 25× | -128.7% | −$129K | −$344K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Antiaging Quantum Living
Antiaging Quantum Living Inc., previously known as Achison Inc., (the “Company”) is a New York corporation formed on December 29, 2014. Our current principal executive office is 135-27 38th Ave #388, Flushing, NY 11354, New York. Tel: 929-990-3255. On July 1, 2019 Lansdale Inc, the principal stockholder of the Company (“Seller”) and controlled by the Company’s prior President, Mr. Wanjun Xie, entered into a Stock Purchase Agreement (the “Agreement”) with Dazhong 368 Inc, (the “Buyer”), pursuant to which, among other things, Seller agreed to sell to the Buyer, and the Buyer agreed to purchase from Seller, a total of 9,000,000 shares of Class A Common Stock of the Company of record and beneficially by Seller. The Purchased Shares represented approximately 90% of the Company’s issued and outstanding shares of Class A Common Stock, resulting in a change of the control of the Company. Mr.
In its own words, from its 10-K, filed Jul 14, 2026.
Antiaging Quantum Living against its Services-Direct Mail Advertising Services peers
The largest companies of the same SEC industry, each at its latest quarter.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| AAQL Antiaging Quantum Living | Q1 FY27 | $730K | +150% | -44.2% |
| HHS Harte Hanks | Q2 2026 | $38.0M | -2% | -11.8% |
Source: Antiaging Quantum Living 10-Q on SEC EDGAR · CIK 1672571 · Services-Direct Mail Advertising Services
More on AAQL
History
Every quarter: Q1 FY27 results · Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results